Global Cancer Profiling Market Size To Worth USD 24.36 Billion by 2032 | CAGR of 9.7%
The Global Cancer Profiling Market Size was valued at USD 9.65 Billion in 2022 and the Worldwide Cancer Profiling Market Size is expected to reach USD 24.36 Billion by 2032, according to a research report published by Spherical Insights & Consulting. Companies Covered: Illumina, Inc., QIAGEN N.V., NeoGenomics, Inc., Sysmex Corporation, HTG Molecular Diagnostics, Inc., Predictive Oncology, Inc., Caris Life Sciences, NanoString Technologies, Inc., Guardant Health, Inc., Foundation Medicine, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genscript Biotech Corporation, Tempus Labs, Hologic, Inc. and Other Key Vendors.
New York, United States, Nov. 21, 2023 (GLOBE NEWSWIRE) — The Global Cancer Profiling Market size is To Grow from USD 9.65 Billion in 2022 to USD 24.36 Billion by 2032, at a Compound Annual Growth Rate (CAGR) of 9.7% during the forecast period.
Get a Sample PDF Brochure: https://www.sphericalinsights.com/request-sample/2484
Cancer profiling, or molecular profiling, is a method that examines the molecular characteristics of a tumor, including genetic mutations and other molecular alterations. This analysis allows oncologists to gain a deeper understanding of the unique nature of a patient’s cancer. By tailoring treatment based on the specific molecular profile, targeted therapies can be employed, increasing the chances of successful outcomes and minimizing adverse effects. Cancer profiling has transformed cancer care, ushering in a new era of personalized medicine, and offering hope for improved treatment efficacy and patient survival rates.
Browse key industry insights spread across 200 pages with 120 Market data tables and figures & charts from the report on “Global Cancer Profiling Market Size, Share, and COVID-19 Impact Analysis, By Technology (Immunoassays, Next-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, In-Situ Hybridization, Microarrays, and Others), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, and Others), By Biomarker Type (Genomic Biomarker, Protein Biomarker, and Others), By Application (Research Application and Clinical Application), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032.”
Buy Now Full Report: https://www.sphericalinsights.com/checkout/2484
Next-generation sequencing segment is expected to grow at the fastest CAGR of around 9.6% during the forecast period
On the basis of the technology, the global cancer profiling market is segmented into immunoassays, next-generation sequencing, polymerase chain reaction, mass spectrometry, in-situ hybridization, microarrays, and others. The next-generation sequencing (NGS) segment is anticipated to experience the fastest growth in the cancer profiling market during the forecast period due to several factors. NGS technology allows for rapid and comprehensive analysis of a patient’s genomic profile, enabling the identification of a wide range of genetic alterations and biomarkers associated with cancer.
The breast cancer segment held the largest market over the forecast period
Based on the cancer type, the global cancer profiling market is segmented into breast cancer, lung cancer, colorectal cancer, prostate cancer, melanoma cancer, and others. The breast cancer segment held the largest market share over the forecast period in the cancer profiling market due to breast cancer is one of the most prevalent cancer types globally, affecting a substantial number of patients. There has been a growing emphasis on early detection and personalized treatment for breast cancer, leading to an increased demand for cancer profiling services.
The genomic biomarker segment held the largest share in cancer profiling market.
Based on the biomarker type, the global cancer profiling market is segmented into genomic biomarker, protein biomarker, and others. The genomic biomarker segment held the largest share in the cancer profiling market due to its crucial role in guiding personalized cancer treatments. Genomic biomarkers provide essential information about genetic mutations and alterations within tumors, allowing clinicians to identify specific therapeutic targets. This targeted approach has gained prominence as it enhances treatment efficacy while minimizing adverse effects.
In 2022, the biomarker discovery segment accounted for around 57.6% market share
Based on the application, the global cancer profiling market is segmented into research application and clinical application. The biomarker discovery segment is a subsegment of research application, that dominates the cancer profiling market due to its pivotal role in identifying novel biomarkers that can aid in cancer diagnosis, prognosis, and treatment selection. Biomarker discovery involves advanced technologies, such as genomics, proteomics, and metabolomics, to explore unique molecular signatures within cancer cells.
Inquire Before Buying This Research Report: https://www.sphericalinsights.com/inquiry-before-buying/2484
Asia-Pacific is predicted to grow at a higher CAGR of around 9.8% over the projected period
Based on region, Asia-Pacific is expected to experience significant growth in the cancer profiling market during the forecast period due to the large and diverse population contributing to a high burden of cancer cases, increasing the demand for personalized and targeted therapies. Improving healthcare infrastructure, rising disposable incomes, and growing awareness about advanced cancer treatments are driving the adoption of cancer profiling technologies in the region. Increasing government initiatives and private investments in oncology research and precision medicine are further propelling market growth.
North America’s dominance in the cancer profiling market can be attributed to research and development, enabling the adoption of advanced genomic technologies and cancer profiling techniques. North America is home to numerous prominent pharmaceutical and biotechnology companies that heavily invest in precision medicine and targeted therapies, driving the demand for cancer profiling services.
The report offers the appropriate analysis of the key organizations/companies involved within the global market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market. Major players in the global cancer profiling market include Illumina, Inc., QIAGEN N.V., NeoGenomics, Inc., Sysmex Corporation, HTG Molecular Diagnostics, Inc., Predictive Oncology, Inc., Caris Life Sciences, NanoString Technologies, Inc., Guardant Health, Inc., Foundation Medicine, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Genscript Biotech Corporation, Tempus Labs, and Hologic, Inc. And Other Key Vendors.
Get Discount At @ https://www.sphericalinsights.com/request-discount/2484
- In January 2022, NeoGenomics, Inc., a leading provider of cancer-focused genetic testing services and global oncology contract research services, has announced a strategic partnership with the Biomarker Collaborative to assist cancer patients who test positive for specific biomarkers in connecting with support groups that include patients with similar findings.
- In May 2022, QIAGEN has introduced the therascreen EGFR Plus RGQ PCR Kit, a novel in-vitro diagnostic test for sensitive EGFR mutation analysis that will help oncologists better advise non-small cell lung cancer (NSCLC) treatment.
This study forecasts revenue at global, regional, and country levels from 2019 to 2032. Spherical Insights has segmented the global cancer profiling market based on the below-mentioned segments:
Cancer Profiling Market, By Technology
- Next-Generation Sequencing
- Polymerase Chain Reaction
- Mass Spectrometry
- In-Situ Hybridization
Cancer Profiling Market, By Cancer Type
- Breast Cancer
- Lung Cancer
- Colorectal Cancer
- Prostate Cancer
- Melanoma Cancer
Cancer Profiling Market, By Biomarker Type
- Genomic Biomarker
- Protein Biomarker
Cancer Profiling Market, By Application
- Research Application
- Clinical Application
Cancer Profiling Market, Regional Analysis
- North America
- Rest of Europe
- Asia Pacific
- South Korea
- Rest of Asia Pacific
- South America
- Rest of South America
- Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of Middle East & Africa
Browse Related Reports
Global Voice-Based Long-Term Care Solutions Market Size, Share, and COVID-19 Impact Analysis, By Product Type (Voice-Activated Assistive Devices, Remote Monitoring Systems, Voice-Integrated Medical Records, and Voice-Controlled Home Automation), By Technology (Microphone Technology, Voice Recognition and Processing, Artificial Intelligence and Machine Learning), By Audio Devices (Wearable Audio Devices, Room-Based Audio Devices, and Ambient Microphone Arrays), By End-User (Individual Patients, Professional Caregivers, Family Caregivers, and Healthcare Facilities), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 – 2032
North America Workplace Wellness Market Size, Share, and COVID-19 Impact Analysis, By Type (Weight Management & Fitness Services, Nutrition & Dietary Plan, Stress Management Services, Health Screening & Assessment, Smoking Cessation), By Delivery Model (Onsite ,Offsite), By End-User (Small Scale organizations, Medium Scale Organizations, Large Scale Organizations), By Country (United States, Canada, Mexico, Rest of North America), and North America Workplace Wellness Market Insights Forecasts 2022 – 2032
Europe Biobanking Market Size, Share, and COVID-19 Impact Analysis, By Type (Equipment, Consumables), By Sample (Human Tissues, Stem Cells, DNA or RNA, Bio-fluids, Others), By Application (Therapeutic Applications, Research Applications, Clinical Trials, Regenerative Medicine), By Country (United Kingdom, Germany, Italy, France, Spain, Netherlands, Rest of Europe), and Europe Biobanking Market Insights, Industry Trend, Forecasts 2022 – 2032
Global Gene Therapy Market Size By Vector Type (Viral Vector, Non-Viral Vector), By Therapy (In Vivo Therapy, Ex Vivo Therapy), By Gene Type (Antigen, Cytokine, Tumor Suppressor, Suicide, Deficiency, Growth factors, Receptors, Others), By Application (Oncological Disorders, Rare Diseases, Neurological Disorders, Other Diseases), By Geographic Scope And Forecast, 2022 – 2032
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company’s mission is to work with businesses to achieve business objectives and maintain strategic improvements.
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Contact Us: https://www.sphericalinsights.com/contact-us
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. AfternoonHeadlines.com takes no editorial responsibility for the same.